Insider · CIK 0002023734
Adiumentum Capital Fund I LP
directorownerother
Files at ATRA (Atara Biotherapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 16, 2025 | ATRA Atara Biotherapeutics, Inc. | AGrant or award Common Stock | +75,572 | $6.61 | $500k | 1,209,395 | May 16, 2025 |
| May 16, 2025 | ATRA Atara Biotherapeutics, Inc. | AGrant or award Warrants (right to buy)derivative | +227,000 | $6.61 | $1.5M | 377,193 | May 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.